Sandler Capital Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-35,660
Closed -$4.82M 209
2024
Q3
$4.82M Sell
35,660
-98,501
-73% -$13.2M 0.64% 66
2024
Q2
$18.2M Sell
134,161
-118,260
-47% -$16.1M 1.95% 7
2024
Q1
$32.6M Buy
252,421
+21,580
+9% +$2.61M 2.38% 5
2023
Q4
$26.4M Buy
230,841
+146,141
+173% +$14.6M 2.19% 5
2023
Q3
$7.71M Buy
+84,700
New +$8.74M 0.79% 50
2016
Q2
Sell
-169,200
Closed -$6.92M 156
2016
Q1
$6.92M Buy
+169,200
New +$6.23M 0.84% 55
2014
Q2
Sell
-291,700
Closed -$10.6M 241
2014
Q1
$10.6M Buy
+291,700
New +$10.6M 0.37% 104

Other funds holding XYL

Sandler Capital Management's XYL Position: Q4 2024 in Review

Sandler Capital Management sold out of Xylem (XYL) in Q4 2024, closing a stake of 35,660 shares — an estimated $4.82M sold.

Sandler Capital Management first reported a position in XYL in Q1 2014 and held it in 7 quarters. The position peaked at $32.6M in Q1 2024. 1,004 funds tracked by Wall St. Rank hold XYL as of Q4 2024.

  • Sandler Capital Management reported no remaining Xylem position as of Q4 2024 after selling out during the quarter.
  • Sandler Capital Management sold 35,660 Xylem shares in Q4 2024, an estimated $4.82M.
  • Sandler Capital Management first reported a position in Xylem in Q1 2014 and held it in 7 quarters.
  • Sandler Capital Management's Xylem position peaked at $32.6M in Q1 2024.
  • 1,004 funds tracked by Wall St. Rank held Xylem as of Q4 2024.

Based on Sandler Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.